Core Insights - Hanwang Technology officially launched its "Business Partner" program to open its core projects to the market, seeking strategic partners with commercialization capabilities and application scenarios [1][4] - The release of the "AI New Scene Industry White Paper" aims to provide a reference for AI innovation to transition from the laboratory to large-scale applications, emphasizing the need for collaboration in commercial paradigms [1][4] - Hanwang maintains high research and development efficiency and commercialization rates, ensuring that innovation does not stagnate, driven by insights into technology trends and a strategy of incremental product development [1][4] Project Highlights - The forum showcased three key projects: the bionic flapping-wing robot bird, the Kersh audio medical electronic blood pressure monitor, and the dual-mode cholesteric liquid crystal display aimed at new display markets [2][5] - Partners are particularly sought who can bring funding, resources, and application scenarios to accelerate projects in mass production, channel development, compliance certification, and operational delivery [2][5]

Core Viewpoint - The article highlights Hanwang Technology's strategic shift from prototype development to closing the loop in AI applications, aiming to accelerate market entry and establish partnerships for commercialization during the AI application boom [1][3]. Group 1: Company Strategy - Hanwang Technology is actively recruiting commercial partners for verified projects to leverage the current AI application explosion and gain a competitive edge in the industry [1][3]. - The company emphasizes transforming innovation from "papers and demos" into "products and scale," showcasing its ability to navigate the complete cycle of artificial intelligence in China [3][5]. - Hanwang's approach focuses on high R&D efficiency and commercialization rates, ensuring that innovations do not stagnate and are rapidly productized [5][7]. Group 2: Key Projects - Hanwang presented three key projects at the forum: a bionic flapping-wing robot bird, a medical electronic sphygmomanometer, and a dual-mode cholesteric liquid crystal display [8]. - The bionic robot bird has achieved significant technological advancements, positioning Hanwang as the largest commercial manufacturer of intelligent bionic birds globally, with applications in inspection, security, and emergency response [9][11]. - The electronic sphygmomanometer utilizes AI to enhance measurement accuracy, outperforming traditional standards, and aims to integrate with health management applications for long-term value [10][11]. - The dual-mode liquid crystal display combines advantages of traditional LCD and EPD technologies, offering features like eye protection and high refresh rates, which are crucial for differentiation in the AI hardware market [14]. Group 3: Investment Opportunities - The recruitment signals from Hanwang indicate a need for partners who can provide funding, resources, and industry insights to accelerate the commercialization of projects [7][15]. - The focus is on finding partners who can contribute to the industrialization process, emphasizing the importance of speed and scalability in the current AI application landscape [15][16]. - Hanwang's shift from showcasing projects to actively seeking collaboration reflects a strategic move towards co-creation and industrial acceleration rather than mere financing [15][16].